HIV Seropositivity
Information
- Disease name
- HIV Seropositivity
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04706624 | Active, not recruiting | N/A | Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics | November 2, 2020 | March 31, 2025 |
| NCT04383223 | Active, not recruiting | N/A | iTransition Development | August 28, 2020 | June 30, 2024 |
| NCT00035893 | Completed | Phase 2 | The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART | May 2001 | August 2006 |
| NCT00130819 | Completed | Phase 2 | Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants | November 2005 | April 2009 |
| NCT00381212 | Completed | Phase 1/Phase 2 | A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. | September 2006 | November 2008 |
| NCT00721305 | Completed | Phase 2 | Lovastatin: Immunomodulatory Value Evaluation | August 2008 | July 2011 |
| NCT05964803 | Completed | Lower Urinary Tract Symptoms in Males Living With HIV | August 1, 2023 | January 1, 2024 | |
| NCT01174914 | Completed | Phase 2 | Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ | March 2008 | March 2010 |
| NCT01733927 | Completed | Phase 3 | An Evaluation of a Rapid Test for HIV | May 2010 | March 2011 |
| NCT01748136 | Completed | Screening for Lung Cancer in the HIV Patient | January 2006 | September 2011 | |
| NCT01813292 | Completed | Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine | May 2013 | July 2014 | |
| NCT01881971 | Completed | Early Phase 1 | Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center | May 2013 | January 2016 |
| NCT02003989 | Completed | Revealing Increased Axonal Loss in Treated HIV Patients | May 2013 | ||
| NCT02082574 | Completed | Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients | July 2013 | ||
| NCT02154971 | Completed | Assessment of Age-related Hearing Loss in HIV-1 Patients | November 18, 2013 | February 26, 2019 | |
| NCT02276326 | Completed | N/A | Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients | July 2014 | June 2019 |
| NCT05674682 | Completed | N/A | Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study | October 1, 2019 | June 30, 2020 |
| NCT02994329 | Completed | N/A | Community-based Distribution of Oral HIV Self-testing Kits | January 18, 2017 | September 30, 2017 |
| NCT05306249 | Completed | Phase 2 | Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients | May 16, 2022 | February 8, 2023 |
| NCT03030768 | Completed | Safer Conception Intervention for HIV-1 Serodiscordant Couples | February 2016 | July 2018 | |
| NCT03124914 | Completed | N/A | Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV | April 19, 2017 | June 12, 2018 |
| NCT03139630 | Completed | COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients | March 2016 | September 2016 | |
| NCT03158987 | Completed | Regional Differences in Human Immunodeficiency Virus (HIV) Testing | June 1, 2017 | January 30, 2019 | |
| NCT03198325 | Completed | N/A | Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia | July 27, 2016 | April 2018 |
| NCT03218839 | Completed | N/A | Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males | October 2015 | May 2016 |
| NCT05074251 | Completed | N/A | Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV | April 20, 2021 | August 24, 2021 |
| NCT04849767 | Completed | National Survey About Trajectory and Life Conditions of HIV Trans People in France | October 1, 2020 | December 31, 2023 | |
| NCT03367130 | Completed | N/A | Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal | October 14, 2017 | June 30, 2018 |
| NCT03374358 | Completed | Phase 4 | Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir | January 10, 2018 | November 30, 2019 |
| NCT04736316 | Completed | N/A | Early Community Client-LED ART Delivery in Nakivale Refugee Settlement | June 29, 2020 | March 31, 2022 |
| NCT03777371 | Completed | Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation | January 1, 2014 | December 1, 2018 | |
| NCT04682990 | Completed | N/A | DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE) | January 5, 2021 | December 5, 2021 |
| NCT03920969 | Completed | Sport and Self Esteem in Patients Living With HIV | February 1, 2019 | December 31, 2019 | |
| NCT04518241 | Completed | N/A | Supporting Health Behavior Among Persons Living With HIV Using Tech, MOST, and Behavioral Economics | August 14, 2020 | July 15, 2022 |
| NCT00006171 | Completed | Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma | August 7, 2000 | June 29, 2012 | |
| NCT06334341 | Enrolling by invitation | N/A | A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP) | February 21, 2024 | April 2028 |
| NCT05983536 | Not yet recruiting | The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex) | September 20, 2023 | July 31, 2025 | |
| NCT05973825 | Not yet recruiting | N/A | Immuno-virological Evaluation of Persons Living With HIV (PLWH) | June 1, 2024 | July 12, 2029 |
| NCT05571319 | Recruiting | Phase 2 | A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome. | August 11, 2022 | June 2024 |
| NCT05723653 | Recruiting | N/A | Hybrid Type I Effectiveness-Implementation Trial of Project nGage | February 13, 2023 | December 31, 2027 |
| NCT05829759 | Recruiting | N/A | Telehealth Delivery (Tele-B6) | April 18, 2023 | December 2026 |
| NCT04062825 | Recruiting | Interaction Between HIV and Platelets | April 17, 2020 | March 2025 | |
| NCT05968183 | Recruiting | The Value of HPV Testing for Cervical Cancer Screening in Women Living With HIV (PAPILLO-VIH) | July 1, 2023 | October 1, 2024 | |
| NCT05268380 | Recruiting | Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia | August 1, 2022 | December 31, 2023 | |
| NCT03987282 | Recruiting | N/A | Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia | April 26, 2022 | August 30, 2025 |
| NCT05118490 | Recruiting | Phase 4 | Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients | July 19, 2023 | December 31, 2024 |
| NCT05122026 | Recruiting | Phase 1/Phase 2 | Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV | January 17, 2024 | March 31, 2025 |
| NCT04832477 | Recruiting | N/A | Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US | September 15, 2021 | February 4, 2026 |
| NCT02848586 | Terminated | N/A | Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers | August 2016 | May 8, 2018 |
| NCT00035581 | Terminated | Phase 2 | Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART | May 2001 | September 2005 |
| NCT05280392 | Terminated | Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial | June 21, 2022 | March 30, 2023 | |
| NCT05174234 | Unknown status | Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana | November 4, 2021 | November 4, 2022 | |
| NCT04088916 | Unknown status | Proviral DNA as a Target for HIV-1 Resistance Analysis | October 15, 2018 | December 31, 2022 | |
| NCT04030689 | Unknown status | Free HIV Testing in Private Biological Laboratories: A New Offer to Encourage HIV Testing | July 1, 2019 | March 31, 2021 | |
| NCT03858478 | Unknown status | Phase 4 | Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST | November 18, 2019 | December 31, 2021 |
| NCT03795415 | Unknown status | ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali | May 27, 2019 | May 2021 | |
| NCT03661203 | Unknown status | Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM | September 2020 | March 2022 | |
| NCT03333083 | Unknown status | Phase 3 | Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen | May 3, 2018 | March 30, 2020 |
| NCT03311945 | Unknown status | Phase 3 | Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM | May 3, 2018 | March 30, 2020 |
| NCT04044586 | Unknown status | HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST) | September 1, 2019 | March 1, 2020 | |
| NCT03004170 | Unknown status | N/A | Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV | December 2016 | December 2021 |
| NCT00797030 | Unknown status | Phase 4 | Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus | October 2006 | November 2008 |
| NCT05672654 | Withdrawn | N/A | Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients | May 10, 2021 | September 1, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006679